Novartis extends Unilife deal for drug delivery device
Novartis has extended a deal with Unilife for the supply of an injectable drug delivery system for use with an early stage drug candidate.
Novartis has extended a deal with Unilife for the supply of an injectable drug delivery system for use with an early stage drug candidate.
Blocking the neuropeptides that regulate arousal and appetite could lead to a treatment for cocaine addiction, says Heptares which has received an NIH development grant.
Demand for biopharmaceutical testing is in part responsible for higher capacity utilisation but, despite encouraging signs, it is too early to say if preclinical pricing will improve accordingly says Envigo.
Polpharma has continued its biosimilar-focused hiring spree and appointed Maurice Chagnaud as its CEO.
A UK supplier of metal catalysts to the drug industry has been fined after an explosion at its site in Widnes left an employee with minor injuries.